Now that the Reddit WallStreetBets trading volatility is once again dying down, one Wall Street analyst upgraded a popular retail investor stock Thursday and said the company’s fundamentals justify a higher share price.
The Bed, Bath & Beyond Analyst: Bank of America analyst Curtis Nagle has reinstated coverage of Bed, Bath & Beyond with a Buy rating and $38 price target.
Related Link: Jim Cramer Clashes With WallStreetBets: 'Forget Stocks, It's Too Hard For You'
The Bed, Bath & Beyond Takeaways: On Thursday, Nagle said Bed, Bath & Beyond shares are once again trading on company fundamentals, and he has a bullish outlook for the stock.
Earlier this month, Bed, Bath & Beyond, which is one of the most heavily shorted stocks in the market relative to its float, soared from under $28 to as high as $44.51 on heavy volume as Redditor’s orchestrated targeted buying campaigns to trigger short squeezes in a handful of stocks.
Yet Bed, Bath & Beyond’s share price has since pulled back to around $30, and Nagle said investors can once again focus on the company’s improving outlook.
“We still believe BBBY is on track to achieve a targeted $850-1,000mn in EBITDA by 2023,” the analyst said.
In the meantime, Nagle said the company has a strong balance sheet, which includes $1.35 billion in cash and a negative net debt of $200 million, which he said could be used to fund the company’s three-year, $1 billion buyback plan.
After Bed, Bath & Beyond reported a $1.01 EPS loss in fiscal 2021 thanks to the pandemic, Nagle is projecting $1.71 in fiscal 2022 EPS and $5.20 in fiscal 2024 EPS.
Benzinga’s Take: Unlike many of the other meme stocks that have terrible fundamentals, Bed, Bath & Beyond is trading at just 17.8 times Nagle’s fiscal 2021 EPS estimate, making it a compelling potential value play for such a heavily shorted stock.
Bed, Bath & Beyond still has an extremely high short percent of float of 31.7%, according to Finviz.
Photo: Anthony92931 via Wikimedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.